IRWD Beats on Q3 Earnings & Revenues, Raises 2025 View, Stock Soars

Key Takeaways IRWD's Q3 earnings of $0.24 per share topped estimates and rose from $0.02 in the prior-year quarter.Revenues rose 33% year over year to $122.1M, driven by Linzess sales growth and profit share from ABBV.Ironwood lifted 2025 revenue guidance to $290-$310M and EBITDA forecast to above $135M.Ironwood Pharmaceuticals (IRWD) reported adjusted earnings of 24 cents per share for the third quarter of 2025, which comprehensively beat the Zacks Consensus Estimate of 9 cents. The company had reported ea ...